Intercure Ltd. Files 2024 Annual Report
Ticker: INCR · Form: 20-F · Filed: May 1, 2025 · CIK: 1857030
| Field | Detail |
|---|---|
| Company | Intercure Ltd. (INCR) |
| Form Type | 20-F |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, financials, pharmaceuticals
TL;DR
Intercure Ltd. dropped its 2024 20-F, check the financials for 2022-2024.
AI Summary
Intercure Ltd. filed its annual 20-F report for the fiscal year ending December 31, 2024. The company, operating in the Pharmaceutical Preparations sector (SIC 2834), is based in Herzliya, Israel. The filing provides financial data for the years 2022, 2023, and 2024, including details on issued capital, capital reserves, retained earnings, and equity attributable to owners of the parent.
Why It Matters
This filing provides investors with a comprehensive overview of Intercure Ltd.'s financial performance and position for the fiscal year 2024, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a 20-F filing, it contains detailed financial information but lacks the immediate forward-looking statements or specific event triggers often found in other SEC filings, making its risk assessment more general.
Key Numbers
- 2024 — Fiscal Year End (The report covers the financial performance up to December 31, 2024.)
- 2023 — Prior Fiscal Year End (Comparative financial data is provided for the year ending December 31, 2023.)
- 2022 — Earlier Fiscal Year End (Comparative financial data is also provided for the year ending December 31, 2022.)
Key Players & Entities
- Intercure Ltd. (company) — Filer of the 20-F report
- 0001857030 (company) — Central Index Key for Intercure Ltd.
- 2834 (dollar_amount) — Standard Industrial Classification code for Pharmaceutical Preparations
- 20241231 (date) — Conformed period of report (fiscal year end)
- 20250501 (date) — Filed as of date
FAQ
What is Intercure Ltd.'s primary business sector?
Intercure Ltd. operates in the Pharmaceutical Preparations sector, identified by the Standard Industrial Classification code 2834.
What is the fiscal year end for Intercure Ltd. as reported in this filing?
The conformed period of report for Intercure Ltd. is December 31, 2024.
When was this 20-F filing submitted to the SEC?
This 20-F filing was submitted to the SEC on May 1, 2025.
Where is Intercure Ltd. headquartered?
Intercure Ltd.'s business and mailing address is located at 85 Medinat Ha-Yehudim Street, Herzliya, Israel.
What financial components are detailed for the fiscal years 2022-2024?
The filing details components such as Issued Capital, Capital Reserve, Retained Earnings, Equity Attributable to Owners of the Parent, and Noncontrolling Interests for the fiscal years ending 2022, 2023, and 2024.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on May 1, 2025 regarding Intercure Ltd. (INCR).